LOS ANGELES, Feb. 23, 2023 (GLOBE NEWSWIRE) -- #" Featured Image for FloQast Featured Image for FloQast

Teva and Medincell Announce FDA Acceptance of Supplemental New Drug Application for UZEDY(R) (risperidone) Extended-Release Injectable Suspension as a Treatment for Patients with Bipolar I Disorder 26-02-2025, 04:00